Home › Funds › Avoro Capital Advisors LLC › KYMR
Avoro Capital Advisors LLC position in KYMR
KYMERA THERAPEUTICS INC · Health Care
Avoro Capital Advisors LLC reported holding 7,474,747 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$835.6M, representing 8.65% of its reported portfolio and ranking #6 among its reported holdings. Avoro Capital Advisors LLC has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's KYMR position evolved
Avoro Capital Advisors LLC first disclosed a stake in KYMR in Q3 2023 at 3,855,000 shares (US$53.6M). The position peaked in Q2 2026 at 7,474,747 shares, worth US$857.1M. Across 13 filings, Avoro Capital Advisors LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 7,474,747 shares valued at US$835.6M. Notable position changes include a 25% increase in Q1 2025 (shares rose 59% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.85M | $53.58M | New |
| Q4 2023 | 3.77M | $96.11M | Reduce |
| Q1 2024 | 3.89M | $156.33M | Add |
| Q2 2024 | 3.89M | $116.08M | Hold |
| Q3 2024 | 4.50M | $212.99M | Add |
| Q4 2024 | 5.15M | $207.18M | Add |
| Q1 2025 | 6.46M | $176.81M | Add |
| Q2 2025 | 6.56M | $286.08M | Add |
| Q3 2025 | 6.35M | $359.41M | Reduce |
| Q4 2025 | 7.47M | $581.61M | Add |
| Q1 2026 | 7.47M | $622.57M | Hold |
| Q2 2026 | 7.47M | $857.13M | Hold |
| Q3 2026 | 7.47M | $835.60M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYMR and 13F data
KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), T. Rowe Price Investment Management, Inc. (US$717.5M), BVF INC/IL (US$444.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYMR
- BAKER BROS. ADVISORS LP 8.66M sh · $992.73M · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.26M sh · $717.52M · Q2 2026
- BVF INC/IL 3.87M sh · $444.01M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.85M sh · $318.33M · Q3 2026
- Siren, L.L.C. 2.78M sh · $311.32M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 808.10K sh · $90.34M · Q3 2026
- Merck & Co., Inc. 772.16K sh · $86.32M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 740.87K sh · $84.96M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 490.61K sh · $54.84M · Q3 2026
- Boxer Capital Management, LLC 429.10K sh · $49.20M · Q2 2026
- Rock Springs Capital Management LP 409.63K sh · $45.79M · Q3 2026
- BRAIDWELL LP 378.16K sh · $43.36M · Q2 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held KYMR?
Avoro Capital Advisors LLC has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Avoro Capital Advisors LLC's current position in KYMR?
As of Q3 2026, Avoro Capital Advisors LLC holds 7.47M shares of KYMR (KYMERA THERAPEUTICS INC), valued at $835.60M, representing 8.65% of its reported portfolio and ranking #6.
Has Avoro Capital Advisors LLC been buying or selling KYMR?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in KYMR. The position peaked in Q2 2026 at 7.47M shares.
Which other funds hold KYMR?
Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, T. Rowe Price Investment Management, Inc., BVF INC/IL, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.